Fresenius Kabi Introduces Heparin Sodium Injection

Fresenius Kabi Introduces Heparin Sodium Injection
BUSINESSWIRE
08 Nov 2019
Share Share
Enforcement Report - Week of July 24, 2019

Enforcement Report - Week of July 24, 2019
FDA
24 Jul 2019
Share Share
FRESENIUS KABI USA`s generic HALOPERIDOL LACTATE Receives Approval in US

FRESENIUS KABI USA`s generic HALOPERIDOL LACTATE Receives Approval in US
FDA
01 Jul 2019
Share Share
Fresenius Kabi`s Generic Micafungin Sodium Receives Approval in US

Fresenius Kabi`s Generic Micafungin Sodium Receives Approval in US
FDA
22 May 2019
Share Share
Fresenius Kabi`s Generic Fentanyl Citrate Receives Approval in US

Fresenius Kabi`s Generic Fentanyl Citrate Receives Approval in US
FDA
08 May 2019
Share Share
Fresenius Kabi`s Generic Sodium Chloride Receives Approval in US

Fresenius Kabi`s Generic Sodium Chloride Receives Approval in US
FDA
15 Mar 2019
Share Share
Fresenius Kabi`s Generic Phenylephrine HCl (ANDA 210666) Receives Approval in US

Fresenius Kabi`s Generic Phenylephrine HCl (ANDA 210666) Receives Approval in US
FDA
30 Jan 2019
Share Share
Fresenius Kabi`s Generic Phenylephrine HCl (ANDA 210665) Receives Approval in US

Fresenius Kabi`s Generic Phenylephrine HCl (ANDA 210665) Receives Approval in US
FDA
29 Jan 2019
Share Share
Fresenius Kabi USA`s Generic Dicyclomine Hydrochloride Receives Approval in US

Fresenius Kabi USA`s Generic Dicyclomine Hydrochloride Receives Approval in US
FDA
25 Jan 2019
Share Share
Enforcement Report - Week of December 12, 2018

Enforcement Report - Week of December 12, 2018
FDA
12 Dec 2018
Share Share

All Pharma News All Pharma News

TOP 10 NEWS OF THE DAY
TOP 10 NEWS
OF THE DAY
NEWS LIBRARY
NEWS
LIBRARY
COMPLIANCE ALERTS
COMPLIANCE
ALERTS
RECENT APPROVALS
RECENT
APPROVALS
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty

PharmaCompass